The pharmaceutical industry held a business analysis meeting in the first half of the year.
Release time:
2020-08-14
Pharmaceutical held a first-half business analysis meeting
called for invigorating spirit, pioneering and innovating, and striving to complete the annual target task
News from our newspaper 7# October 10 , Pharmaceutical Company held a first-half business analysis meeting in Jinxi Pharmaceutical Factory to summarize the work in the first half and arrange the work plan for the second half.
Various departments and subordinate enterprises of Pharmaceutical Company reported their work in the first half of the year and put forward their work plans and objectives for the second half of the year. Chief Financial Officer Gong Xiliang analyzed the operation of Pharmaceutical Company in the first half of the year. General Manager Huang Jinlong summarized the work of the pharmaceutical company in the first half of the year, analyzed the existing problems and difficulties, and made arrangements for the work in the second half of the year.
In the first half of this year, the new medical reform and industry supervision have been strengthened day by day. All employees of the pharmaceutical company have worked hard and achieved a series of new results: the national first-class anti-tumor drug deoxypodophyllotoxin for injection has obtained clinical approval and is expected to be included in the national "13th Five-Year Plan" major new drug creation science and technology major project; Desvenlafaxine Succinate Sustained Release Tablets were included in Jinhua Key Science and Technology Innovation Project; jianfeng Pharmaceutical was named 2016 National Intellectual Property Advantage Enterprise by the State Intellectual Property Office. Signed the "Agreement on Capital Increase and Share Transfer of Beijing Huibaoyuan Biotechnology Co., Ltd." and completed the first phase of investment. Bidding and negotiation have achieved phased results. Peak natural products continue to maintain a good momentum of development; Major pharmacies have strengthened in-depth cooperation with hospitals and achieved results; the "three downsides and three improvements" have continued to play an important role in tapping internal potential.
Facing the severe external environment and internal operating pressure, the pharmaceutical company will mainly do the following work in the second half of the year: strengthen marketing management and broaden new space for marketing work; Speed up the pace of new drug development, improve efficiency, and improve quality; Standardize management and improve the level of operation and management, from quality management, internal control management, receivables and inventory management, human resource management, three reductions and three improvements, etc, systematically improve the level of internal management; speed up the pace of information construction, promote the process of internationalization, pay close attention to technological transformation projects, and enhance the stamina of enterprise development. At the
meeting, Huang Jinlong asked all employees to cheer up, change pressure into motivation, find ways to promote all kinds of work in a planned, targeted, measured and responsible way, and work hard to achieve the annual goal of the pharmaceutical company. (This correspondent)
More information
The company's vocational skill level independently identifies two new occupations
A few days ago, after the examination and approval of the Jinhua Municipal Bureau of Human Resources and Social Security, and reported to the Provincial Department of Human Resources and Social Security for examination and filing, Jianfeng Group's independent identification level of vocational skills was based on last year. Two new occupations (types of work) are chemical inspectors and organic synthesis workers.
2022
05-20
On May 12, Cai Xiaochun, deputy secretary of the Party group of Zhejiang Federation of industry and commerce, and his party visited Jianfeng group for investigation, visited Jinxi factory area of Jianfeng pharmaceutical factory and Jinxi internationalization project site, and had a discussion with Jiang Xiaomeng, chairman of the group company, Huang Jinlong, deputy general manager of the group company and general manager of the pharmaceutical company.
2022
05-20
On the afternoon of April 6, Jiang Xiaomeng, chairman of the group company, was invited to participate in the Jinhua News Client Financial Media Interview column "Night Talk of the Two Sessions", as a representative of the Jinhua Municipal People's Congress, to talk about suggestions for the future development of Jinhua enterprises. As the chairman of the Jinhua City Federation of Industry and Commerce, Jiang Xiaomeng has a personal experience of various problems encountered in the development of Jinhua enterprises. After careful investigation and full preparation, he put forward two proposals on strengthening the empowerment and allocation of production factors and further enhancing the market competitiveness of enterprises in our city and further promoting the compliance construction of private enterprises in our city and reducing the risk of enterprise operation. In the "two sessions night talk" interview, he put forward his own views on these two topics.
2022
04-12
Group Companies Commend 2021 Advanced
On the morning of January 26, the group company held the 2021 annual summary commendation meeting to review the work of the previous year, make arrangements for the work of 2022, sign the 2022 economic responsibility system with various professional companies and directly affiliated enterprises, and solemnly commend the 2021 advanced collectives and individuals.
2022
02-08
Group Company Convenes Workers' Representative and Trade Union Member Representative Conference
The group company held a representative meeting of staff representatives and trade union members, elected members of the eighth trade union committee and members of various special committees, and Shi Fu was elected chairman of the eighth trade union of the group trade union.
2022
02-08
The group company held an annual safety and environmental protection work conference to comprehensively summarize and review the safety and environmental protection work in 2021, make arrangements for the safety and environmental protection work in 2022, and sign the safety and environmental protection work responsibility system.
2022
02-08
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page